Daily Insider Signal · July 17, 2026
Insider Alert: Filius Bart Bought PRQR Shares (90/100 Signal)
Ticker
PRQR
Action
Bought
Shares
150,000
Signal Score
90/100
Filius Bart bought 150,000 shares of ProQR Therapeutics N.V. (PRQR) at $1.72 for a total transaction value of $257,925.
This trade scores 90/100, indicating very high conviction. Large open-market purchases by C-suite executives with minimal noise factors are rare and historically correlated with positive 90-day forward returns.
The purchase increased the insider's holdings by approximately 50%, a significant position expansion that often signals strong internal confidence.
What to watch: Monitor upcoming earnings dates, any subsequent Form 4 amendments, and cluster activity (multiple insiders buying within a 30-day window). Single-insider signals are most powerful when corroborated by broader insider clustering or supportive technical trends.
This trade scores 90/100, indicating very high conviction. Large open-market purchases by C-suite executives with minimal noise factors are rare and historically correlated with positive 90-day forward returns.
The purchase increased the insider's holdings by approximately 50%, a significant position expansion that often signals strong internal confidence.
What to watch: Monitor upcoming earnings dates, any subsequent Form 4 amendments, and cluster activity (multiple insiders buying within a 30-day window). Single-insider signals are most powerful when corroborated by broader insider clustering or supportive technical trends.
What this signal means
DisclosureSignals scores every SEC Form 4 filing on a 0–100 scale. This trade earned a 90/100 signal score by weighing the transaction type, insider role, trade size, cluster buying, the insider's own history, and whether the trade was discretionary rather than part of a scheduled 10b5-1 plan. A higher score indicates a more unusual, conviction-driven purchase. Read the full methodology.
See every recent Form 4 filing for PRQR, including historical insider trades and trend context.
Transaction Details
- Insider
- Filius Bart
- Company
- ProQR Therapeutics N.V.
- Transaction Date
- July 17, 2026
- Price Per Share
- $1.72
- Total Value
- $257,925
- Type
- Purchase
Get Real-Time Insider Alerts
DisclosureSignals monitors SEC EDGAR every 15 minutes and scores every Form 4 filing. Don't miss the next high-conviction signal.
View Free Dashboard →